Algen Biotechnologies

Many cancers and inflammatory diseases lack effective treatments because the key disease-driving RNA signals are difficult to identify and target.

Algen uses CRISPR and machine learning to discover and develop first-in-class drugs that modulate disease-driving RNA messages at single-cell resolution.

Pharmaceutical and biotechnology companies developing therapies for cancer, inflammation, and other high unmet-need diseases.